Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith McCrae

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cancer Chemotherapy and Pharmacology|November 13, 2004
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neckMatthew M Cooney, Kou-Yi Tserng, Vinit Makar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkersJoseph Baar, Paula Silverman, Janice Lyons, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (a workshop report of the NHLBI)Jerrold H Levy, Peta M A Alexander, Alisa S Wolberg, et al.
Transfusion|September 28, 2006
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpuraPaul D Mintz, Anne Neff, Malcolm MacKenzie, et al.
The Journal of Clinical Investigation|June 30, 2020
Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitisKatarzyna Bulek, Junjie Zhao, Yun Liao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicinBeth Overmoyer, Pingfu Fu, Charles Hoppel, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2014
Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactionsAnna Sala-Cunill, Jenny Björkqvist, Riccardo Senter, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Chemotherapy and Pharmacology|November 13, 2004
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neckMatthew M Cooney, Kou-Yi Tserng, Vinit Makar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkersJoseph Baar, Paula Silverman, Janice Lyons, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (a workshop report of the NHLBI)Jerrold H Levy, Peta M A Alexander, Alisa S Wolberg, et al.
Transfusion|September 28, 2006
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpuraPaul D Mintz, Anne Neff, Malcolm MacKenzie, et al.
The Journal of Clinical Investigation|June 30, 2020
Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitisKatarzyna Bulek, Junjie Zhao, Yun Liao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicinBeth Overmoyer, Pingfu Fu, Charles Hoppel, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2014
Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactionsAnna Sala-Cunill, Jenny Björkqvist, Riccardo Senter, et al.
Pageof 4